A Safety and Tolerability Study of Neural Stem Cells (NR1) in Subjects With Chronic Ischemic Subcortical Stroke (ISS)
Clinical trial NCT04631406 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04631406
- Sponsor
- Clarion Cells, Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-01-04
- Primary completion
- 2025-08-12
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.